Literature DB >> 12171576

GABA(A)-receptor ligands of flavonoid structure.

Mariel Marder1, Alejandro C Paladini.   

Abstract

This review describes the new research developments that have established the CNS-activity of some natural flavonoids. The properties of flavone, chrysin, apigenin and cirsiliol are described and a survey of the occurrence of ligands for the benzodiazepine binding site in the flavonoid field is attempted. Natural compounds, structurally related to flavonoids and with similar CNS-activities, are also included. A medicinal chemistry approach to improve the biochemical and pharmacological properties of the flavone nucleus is described alongside with the enumeration of the principal achievements obtained to date. Quantitative structure-activity relationships studies leading to the formulation of pharmacophore models presumably describing the characteristics of the flavone-binding site in the GABA(A)-receptor are summarized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171576     DOI: 10.2174/1568026023393462

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  21 in total

1.  Flavonoids: some of the wisdom of sage?

Authors:  G A R Johnston; P M Beart
Journal:  Br J Pharmacol       Date:  2004-07       Impact factor: 8.739

2.  In vitro antiproliferative characteristics of flavonoids and diazepam on SNU-C4 colorectal adenocarcinoma cells.

Authors:  Sang-Woo Lee; Jae-Tae Lee; Maan-Gee Lee; Ho Won Lee; Sohn Joo Ahn; Yong Jin Lee; You La Lee; Jeongsoo Yoo; Byeong-Cheol Ahn; Jeoung-Hee Ha
Journal:  J Nat Med       Date:  2008-12-03       Impact factor: 2.343

3.  Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method.

Authors:  S-M Elsas; D J Rossi; J Raber; G White; C-A Seeley; W L Gregory; C Mohr; T Pfankuch; A Soumyanath
Journal:  Phytomedicine       Date:  2010-04-10       Impact factor: 5.340

Review 4.  Awareness and current knowledge of epilepsy.

Authors:  Asmat Ullah Khan; Muhammad Akram; Muhammad Daniyal; Naheed Akhter; Muhammad Riaz; Naheed Akhtar; Mohammad Ali Shariati; Fozia Anjum; Samreen Gul Khan; Abida Parveen; Saeed Ahmad
Journal:  Metab Brain Dis       Date:  2019-10-11       Impact factor: 3.584

5.  Putative Antidepressant Effect of Chamomile (Matricaria chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression.

Authors:  Jay D Amsterdam; Qing S Li; Sharon X Xie; Jun J Mao
Journal:  J Altern Complement Med       Date:  2019-12-05       Impact factor: 2.579

6.  Hesperidin, a flavone glycoside, as mediator of neuronal survival.

Authors:  Jader Nones; Tania Cristina Leite de Sampaio E Spohr; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2011-05-08       Impact factor: 3.996

7.  Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells.

Authors:  Omar A Harasstani; Saidi Moin; Chau Ling Tham; Choi Yi Liew; Norazren Ismail; Revathee Rajajendram; Hanis H Harith; Zainul A Zakaria; Azam S Mohamad; Mohamad R Sulaiman; Daud A Israf
Journal:  Inflamm Res       Date:  2010-03-11       Impact factor: 4.575

8.  Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.

Authors:  John R Keefe; Jun J Mao; Irene Soeller; Qing S Li; Jay D Amsterdam
Journal:  Phytomedicine       Date:  2016-10-24       Impact factor: 5.340

9.  The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice.

Authors:  Sebastian P Fernandez; Michael Nguyen; Tin Thing Yow; Cindy Chu; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

10.  Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.

Authors:  Jun J Mao; Qing S Li; Irene Soeller; Kenneth Rockwell; Sharon X Xie; Jay D Amsterdam
Journal:  J Clin Trials       Date:  2014-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.